TYMS and colorectal cancer: The aim of our work was to evaluate the clinical outcome and toxicity of colorectal cancer patients on adjuvant treatment with 5FU in relation with demographic characteristics, known TYMS and MTHFR polymorphisms, and individual 5FU CL.